Skip to main content
Top
Published in: Cardiovascular Diabetology 1/2009

Open Access 01-12-2009 | Original investigation

Elevated resting heart rate is associated with the metabolic syndrome

Authors: Ori Rogowski, Arie Steinvil, Shlomo Berliner, Michael Cohen, Nili Saar, Orit Kliuk Ben-Bassat, Itzhak Shapira

Published in: Cardiovascular Diabetology | Issue 1/2009

Login to get access

Abstract

Background

Increased resting heart rate (RHR) may be associated with increased cardiovascular morbidity. Our aim was to explore the possibility that increased RHR is associated with the prevalence of the metabolic syndrome (MetS) in a sample of apparently healthy individuals and those with cardiovascular risk factors.

Methods

We performed a cross-sectional analysis in a large sample of apparently healthy individuals who attended a general health screening program and agreed to participate in our survey. We analyzed a sample of 7706 individuals (5106 men and 2600 women) with 13.2% of men and 8.9% of the women fulfilling the criteria for the MetS. The participants were divided into quintiles of resting heart rate. Multiple adjusted odds ratio was calculated for having the MetS in each quintile compared to the first.

Results

The multi-adjusted odds for the presence of the MetS increased gradually from an arbitrarily defined figure of 1.0 in the lowest RHR quintile (<60 beats per minute (BPM) in men and <64 BPM in women) to 4.1 and 4.2 in men and women respectively in the highest one (≥80 BPM in men and ≥82 BPM in women).

Conclusion

Raised resting heart rate is significantly associated with the presence of MetS in a group of apparently healthy individuals and those with an atherothrombotic risk. The strength of this association supports the potential presence of one or more shared pathophysiological mechanisms for both RHR and the MetS.
Appendix
Available only for authorised users
Literature
1.
go back to reference Diaz A, Bourassa MG, Guertin MC, Tardif JC: Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005, 26: 967-974. 10.1093/eurheartj/ehi190.CrossRefPubMed Diaz A, Bourassa MG, Guertin MC, Tardif JC: Long-term prognostic value of resting heart rate in patients with suspected or proven coronary artery disease. Eur Heart J. 2005, 26: 967-974. 10.1093/eurheartj/ehi190.CrossRefPubMed
2.
go back to reference Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M: Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007, 50: 823-830. 10.1016/j.jacc.2007.04.079.CrossRefPubMed Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, Steg PG, Tardif JC, Tavazzi L, Tendera M: Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007, 50: 823-830. 10.1016/j.jacc.2007.04.079.CrossRefPubMed
3.
go back to reference Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R: Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008, 372: 817-821. 10.1016/S0140-6736(08)61171-X.CrossRefPubMed Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R: Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial. Lancet. 2008, 372: 817-821. 10.1016/S0140-6736(08)61171-X.CrossRefPubMed
4.
go back to reference Tverdal A, Hjellvik V, Selmer R: Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40-45 years. Eur Heart J. 2008, 29: 2772-2781. 10.1093/eurheartj/ehn435.CrossRefPubMed Tverdal A, Hjellvik V, Selmer R: Heart rate and mortality from cardiovascular causes: a 12 year follow-up study of 379,843 men and women aged 40-45 years. Eur Heart J. 2008, 29: 2772-2781. 10.1093/eurheartj/ehn435.CrossRefPubMed
5.
go back to reference Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007, 49: 2112-2119. 10.1016/j.jacc.2007.01.088.CrossRefPubMed Jeppesen J, Hansen TW, Rasmussen S, Ibsen H, Torp-Pedersen C, Madsbad S: Insulin resistance, the metabolic syndrome, and risk of incident cardiovascular disease: a population-based study. J Am Coll Cardiol. 2007, 49: 2112-2119. 10.1016/j.jacc.2007.01.088.CrossRefPubMed
6.
go back to reference Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112: 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed Wilson PW, D'Agostino RB, Parise H, Sullivan L, Meigs JB: Metabolic syndrome as a precursor of cardiovascular disease and type 2 diabetes mellitus. Circulation. 2005, 112: 3066-3072. 10.1161/CIRCULATIONAHA.105.539528.CrossRefPubMed
7.
go back to reference Steinvil A, Berliner S, Bromberg M, Cohen M, Shalev V, Shapira I, Rogowski O: Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: Potential triggers for atherothrombotic events. Atherosclerosis. 2009, 206: 270-5. 10.1016/j.atherosclerosis.2009.01.045.CrossRefPubMed Steinvil A, Berliner S, Bromberg M, Cohen M, Shalev V, Shapira I, Rogowski O: Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: Potential triggers for atherothrombotic events. Atherosclerosis. 2009, 206: 270-5. 10.1016/j.atherosclerosis.2009.01.045.CrossRefPubMed
8.
go back to reference Rogowski O, Shapira I, Berliner S: Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome. Metabolism. 2008, 57: 1221-1226. 10.1016/j.metabol.2008.04.015.CrossRefPubMed Rogowski O, Shapira I, Berliner S: Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome. Metabolism. 2008, 57: 1221-1226. 10.1016/j.metabol.2008.04.015.CrossRefPubMed
9.
go back to reference Rogowski O, Shapira I, Steinvil A, Berliner S: Low grade inflammation in individuals with the hypertriglyceridemic waist phenotype. Another feature of the atherogenic dysmetabolism. Metabolism. 2009, 58: 661-667. 10.1016/j.metabol.2009.01.005.CrossRefPubMed Rogowski O, Shapira I, Steinvil A, Berliner S: Low grade inflammation in individuals with the hypertriglyceridemic waist phenotype. Another feature of the atherogenic dysmetabolism. Metabolism. 2009, 58: 661-667. 10.1016/j.metabol.2009.01.005.CrossRefPubMed
10.
go back to reference Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S: Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart. 2007, 93: 940-944. 10.1136/hrt.2006.101949.PubMedCentralCrossRefPubMed Rogowski O, Shapira I, Shirom A, Melamed S, Toker S, Berliner S: Heart rate and microinflammation in men: a relevant atherothrombotic link. Heart. 2007, 93: 940-944. 10.1136/hrt.2006.101949.PubMedCentralCrossRefPubMed
11.
go back to reference Rogowski O, Toker S, Shapira I, Melamed S, Shirom A, Zeltser D, Berliner S: Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol. 2005, 95: 152-155. 10.1016/j.amjcard.2004.08.086.CrossRefPubMed Rogowski O, Toker S, Shapira I, Melamed S, Shirom A, Zeltser D, Berliner S: Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol. 2005, 95: 152-155. 10.1016/j.amjcard.2004.08.086.CrossRefPubMed
12.
go back to reference Steinvil A, Shirom A, Melamed S, Toker S, Justo D, Saar N, Shapira I, Berliner S, Rogowski O: Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol. 2008, 102: 1034-1039. 10.1016/j.amjcard.2008.05.055.CrossRefPubMed Steinvil A, Shirom A, Melamed S, Toker S, Justo D, Saar N, Shapira I, Berliner S, Rogowski O: Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol. 2008, 102: 1034-1039. 10.1016/j.amjcard.2008.05.055.CrossRefPubMed
13.
go back to reference Zeltser D, Rogowski O, Mardi T, Justo D, Tolshinsky T, Goldin Y, Burke M, Deutsch V, Berliner S, Shapira I: Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein. Atherosclerosis. 2004, 176: 297-301. 10.1016/j.atherosclerosis.2004.04.015.CrossRefPubMed Zeltser D, Rogowski O, Mardi T, Justo D, Tolshinsky T, Goldin Y, Burke M, Deutsch V, Berliner S, Shapira I: Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein. Atherosclerosis. 2004, 176: 297-301. 10.1016/j.atherosclerosis.2004.04.015.CrossRefPubMed
14.
go back to reference Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). Jama. 2001, 285: 2486-2497. 10.1001/jama.285.19.2486.
15.
go back to reference Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003, 26: 3160-3167. 10.2337/diacare.26.12.3331.CrossRefPubMed Genuth S, Alberti KG, Bennett P, Buse J, Defronzo R, Kahn R, Kitzmiller J, Knowler WC, Lebovitz H, Lernmark A: Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003, 26: 3160-3167. 10.2337/diacare.26.12.3331.CrossRefPubMed
16.
go back to reference Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, Gordon DJ, Krauss RM, Savage PJ, Smith SC: Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation. 2005, 112: 2735-2752. 10.1161/CIRCULATIONAHA.105.169404.CrossRefPubMed
17.
go back to reference Schultz HD, Li YL, Ding Y: Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension. 2007, 50: 6-13. 10.1161/HYPERTENSIONAHA.106.076083.CrossRefPubMed Schultz HD, Li YL, Ding Y: Arterial chemoreceptors and sympathetic nerve activity: implications for hypertension and heart failure. Hypertension. 2007, 50: 6-13. 10.1161/HYPERTENSIONAHA.106.076083.CrossRefPubMed
18.
go back to reference Landsberg L: Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system. J Cardiovasc Pharmacol. 1994, 23 (Suppl 1): S1-8. 10.1097/00005344-199423001-00002.CrossRefPubMed Landsberg L: Pathophysiology of obesity-related hypertension: role of insulin and the sympathetic nervous system. J Cardiovasc Pharmacol. 1994, 23 (Suppl 1): S1-8. 10.1097/00005344-199423001-00002.CrossRefPubMed
19.
go back to reference Landsberg L: Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001, 19: 523-528. 10.1097/00004872-200103001-00001.CrossRefPubMed Landsberg L: Insulin-mediated sympathetic stimulation: role in the pathogenesis of obesity-related hypertension (or, how insulin affects blood pressure, and why). J Hypertens. 2001, 19: 523-528. 10.1097/00004872-200103001-00001.CrossRefPubMed
20.
go back to reference Mujica-Parodi LR, Renelique R, Taylor MK: Higher body fat percentage is associated with increased cortisol reactivity and impaired cognitive resilience in response to acute emotional stress. Int J Obes (Lond). 2009, 33: 157-165. 10.1038/ijo.2008.218.CrossRef Mujica-Parodi LR, Renelique R, Taylor MK: Higher body fat percentage is associated with increased cortisol reactivity and impaired cognitive resilience in response to acute emotional stress. Int J Obes (Lond). 2009, 33: 157-165. 10.1038/ijo.2008.218.CrossRef
21.
go back to reference Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD: Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999, 17: 1125-1133. 10.1097/00004872-199917080-00012.CrossRefPubMed Rumantir MS, Vaz M, Jennings GL, Collier G, Kaye DM, Seals DR, Wiesner GH, Brunner-La Rocca HP, Esler MD: Neural mechanisms in human obesity-related hypertension. J Hypertens. 1999, 17: 1125-1133. 10.1097/00004872-199917080-00012.CrossRefPubMed
22.
go back to reference Gerich JE: Control of glycaemia. Baillieres Clin Endocrinol Metab. 1993, 7: 551-586. 10.1016/S0950-351X(05)80207-1.CrossRefPubMed Gerich JE: Control of glycaemia. Baillieres Clin Endocrinol Metab. 1993, 7: 551-586. 10.1016/S0950-351X(05)80207-1.CrossRefPubMed
23.
go back to reference Landsberg L: Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens A. 1990, 12: 817-830. 10.3109/10641969009073502.PubMed Landsberg L: Insulin resistance, energy balance and sympathetic nervous system activity. Clin Exp Hypertens A. 1990, 12: 817-830. 10.3109/10641969009073502.PubMed
24.
go back to reference Bray GA: Autonomic and endocrine factors in the regulation of food intake. Brain Res Bull. 1985, 14: 505-510. 10.1016/0361-9230(85)90098-X.CrossRefPubMed Bray GA: Autonomic and endocrine factors in the regulation of food intake. Brain Res Bull. 1985, 14: 505-510. 10.1016/0361-9230(85)90098-X.CrossRefPubMed
25.
go back to reference Deniz F, Katircibasi MT, Pamukcu B, Binici S, Sanisoglu SY: Association of metabolic syndrome with impaired heart rate recovery and low exercise capacity in young male adults. Clin Endocrinol (Oxf). 2007, 66: 218-223. 10.1111/j.1365-2265.2006.02711.x.CrossRef Deniz F, Katircibasi MT, Pamukcu B, Binici S, Sanisoglu SY: Association of metabolic syndrome with impaired heart rate recovery and low exercise capacity in young male adults. Clin Endocrinol (Oxf). 2007, 66: 218-223. 10.1111/j.1365-2265.2006.02711.x.CrossRef
26.
go back to reference Jonkers IJ, de Man FH, Laarse van der A, Frolich M, Gevers Leuven JA, Kamper AM, Blauw GJ, Smelt AH: Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia. J Hypertens. 2001, 19: 749-755. 10.1097/00004872-200104000-00012.CrossRefPubMed Jonkers IJ, de Man FH, Laarse van der A, Frolich M, Gevers Leuven JA, Kamper AM, Blauw GJ, Smelt AH: Bezafibrate reduces heart rate and blood pressure in patients with hypertriglyceridemia. J Hypertens. 2001, 19: 749-755. 10.1097/00004872-200104000-00012.CrossRefPubMed
Metadata
Title
Elevated resting heart rate is associated with the metabolic syndrome
Authors
Ori Rogowski
Arie Steinvil
Shlomo Berliner
Michael Cohen
Nili Saar
Orit Kliuk Ben-Bassat
Itzhak Shapira
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Diabetology / Issue 1/2009
Electronic ISSN: 1475-2840
DOI
https://doi.org/10.1186/1475-2840-8-55

Other articles of this Issue 1/2009

Cardiovascular Diabetology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.